Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Reg Anesth Pain Med ; 32(1): 55-9, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17196493

RESUMO

BACKGROUND AND OBJECTIVES: The surgical site for the creation of an arteriovenous fistula at the lateral aspect of the distal forearm may be faster and more effectively blocked with the infraclavicular coracoid approach than with the axillary approach for brachial plexus block. METHODS: Sixty uremic patients scheduled for the creation of an arteriovenous fistula at the forearm were randomized to receive a single-injection brachial plexus block with 35 to 50 mL mepivacaine 0.95% with epinephrine using the infraclavicular coracoid approach (IC group) or the perivascular axillary approach (AX group). A distal muscular contraction elicited by a nerve stimulator at current <0.5 mA was used in all patients. RESULTS: At 30 and 45 minutes, complete loss of sensation was observed more often in group IC than AX in the cutaneous distribution of musculocutaneous nerve (62% v 30% [P < .05] and 69% v 40%, respectively [P < .05]), but at 60 minutes the difference was not statistically significant. In other areas, analgesia and motor block were achieved at a similar rate. In 3 patients surgery could not be performed under the block due to changes in schedule or the use of a brachial tourniquet. Patient satisfaction was equally high in both groups. CONCLUSIONS: Blockade of the musculocutaneous nerve developed faster with the infraclavicular coracoid approach than with the axillary approach. The infraclavicular coracoid approach may be preferable in patients scheduled for the creation of an arteriovenous fistula at the forearm.


Assuntos
Derivação Arteriovenosa Cirúrgica , Axila , Plexo Braquial , Clavícula , Antebraço/cirurgia , Bloqueio Nervoso , Adulto , Idoso , Idoso de 80 Anos ou mais , Anestésicos Locais , Eletrocardiografia , Feminino , Humanos , Lidocaína , Masculino , Pessoa de Meia-Idade , Movimento , Nervo Musculocutâneo , Bloqueio Nervoso/efeitos adversos , Medição da Dor , Taquicardia/induzido quimicamente , Uremia/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA